Glaxo Consumer Finds Growth Groove Via Innovation, Acquisitions, Expansion
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline's consumer health care business appears back on track with 8 percent growth in the firm's latest earnings period, a year after it reported flat consumer sales hurt by the disappointing U.S. performance of weight-loss drug alli